Tratamiento de la enfermedad hepática grasa no alcohólica

Gutt, Susana; Álvarez, María; Yuma, María; Ackermann, Marianela; Coronel, María; Gauna, Carla; González, Sandra; Lifszyc, Paula; Menéndez, Estrella; Mociusky, Juliana; Musso, Carla; Polo, Paola; Salinas, Victoria; Fuentes, Susana.
Rev. Soc. Argent. Diabetes ; 52(1): 10-24, Abril 2018. ilus, grafs
Artículo en Español | LILACS | ID: biblio-1087423

Documentos relacionados

  1. Sarcopenic obesity in fatty liver.
  2. Reply.
  3. Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.
  4. Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids.
  5. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
  6. Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Enough Data to be Considered Effective?
  7. Bariatric Surgery Decreases the Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis.
  8. Do We Need a Randomized Controlled Trial on This Issue? Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery.
  9. How best to combine liver transplantation and bariatric surgery?-Results from a global, web-based survey.
  10. Bariatric surgery and liver transplant.